In particular, pleiotropic mechanisms have been proposed to underlie the action of SIM against cancers (Chiu et al., 2011), such as inhibiting tumour cell proliferation, migration and invasion, and promoting apoptosis by simultaneously targeting YAP and β-catenin signalling (Liu et al., 2020). Here, SIM2 is linked to cancer.